• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CTE
Click for more information
0.00% 85.0¢

CRYOSITE LIMITED - Announcements

Market Cap $39.04M  ! watchlist Created with Sketch. Add to my watchlist

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The... Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CTE Appendix 4D and Half Year AccountsPRICE SENSITIVE26/02/19
CTE Federal Court approves in principle settlementPRICE SENSITIVE13/02/19
CTE Cryosite reaches in principle settlement with ACCCPRICE SENSITIVE08/02/19
CTE Results of Meeting23/11/18
CTE Notice of General Meeting/Proxy Form19/10/18
CTE Corporate Governance Statement30/08/18
CTE Appendix 4G30/08/18
CTE Appendix4E and Annual reportPRICE SENSITIVE30/08/18
CTE Trading UpdatePRICE SENSITIVE02/08/18
CTE ACCC proceedingsPRICE SENSITIVE12/07/18 download Created with Sketch. 108.86KB
CTE Change in substantial holding27/03/18
CTE Change of Director's Interest Notice27/03/18
CTE Change in substantial holding16/03/18
CTE Change of Director's Interest Notice16/03/18
CTE Initial Director's Interest Notice05/03/18
CTE Director appointment05/03/18
CTE Final Director's Interest Notice02/03/18
CTE Director resignation02/03/18
CTE Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/18
CTE Appendix 3B16/02/18
CTE Appointment of CEOPRICE SENSITIVE17/01/18
CTE Cell Care transaction not to proceed. Meeting CancelledPRICE SENSITIVE09/01/18
CTE ACCC update21/12/17
CTE ACCC ends review of Cell Care's Cryosite assets acquisitionPRICE SENSITIVE21/12/17
CTE Notice of General Meeting/Proxy Form14/12/17
CTE Appendix 3B01/12/17
CTE Appendix 3B28/11/17
CTE Trading updatePRICE SENSITIVE22/11/17
CTE ACCC updatePRICE SENSITIVE08/11/17
CTE Results of Meeting03/11/17
CTE Chairman's Address to ShareholdersPRICE SENSITIVE03/11/17
CTE Change of Director's Interest Notice11/10/17
CTE Notice of Annual General Meeting/Proxy Form29/09/17
CTE Appendix 4G and Corporate Governance Statement23/08/17
CTE Appendix 4E and Annual ReportPRICE SENSITIVE23/08/17
CTE ACCC review of proposed transaction of Cord Blood assetsPRICE SENSITIVE04/08/17
CTE Change in substantial holding03/07/17
CTE Change of Director's Interest Notice03/07/17
CTE Appendix 3c - share buyback23/06/17
CTE Cryosite to license its CB&T brand and sell certain assetsPRICE SENSITIVE23/06/17
CTE Appointment of Interim CEOPRICE SENSITIVE15/06/17
CTE Resignation of CEOPRICE SENSITIVE19/05/17
CTE CEO - introduction of short and long term incentive plan08/03/17
CTE Appendix 3B - performance rights08/03/17
CTE Dividend/Distribution - CTE22/02/17
CTE Appendix 4D and Half Year AccountsPRICE SENSITIVE22/02/17
CTE Revised Share Trading Policy07/02/17
CTE Change of Director's Interest Notice06/01/17
CTE Change of Director's Interest Notice - S Roberts20/12/16
CTE Change of Director's Interest Notice - S Roberts13/12/16
CTE Director appointment resignation appendix 3x and 3y-CTE.AX 03/11/16
CTE Director appointment resignation appendix 3x and 3y03/11/16
CTE Results of Meeting-CTE.AX 27/10/16
CTE Chairman's Address to Shareholders-CTE.AX 27/10/16
CTE Notice of General Meeting/Proxy Form-CTE.AX 22/09/16
CTE Change in substantial holding-CTE.AX 01/09/16
CTE Change of Director's Interest Notice-CTE.AX 01/09/16
CTE Appendix 4G and Corporate Governance Statement-CTE.AX 24/08/16
CTE Dividend/Distribution - CTE-CTE.AX 24/08/16
CTE Appendix 4E and audited annual report-CTE.AX PRICE SENSITIVE24/08/16
CTE Change of Director's Interest Notice-CTE.AX 05/07/16
CTE Appointment of CEO-CTE.AX PRICE SENSITIVE08/06/16
CTE Corporate Governance Statement-CTE.AX 21/04/16
CTE Change in position of Chairman-CTE.AX 11/04/16
CTE Cryosite assists Stemlife customers-CTE.AX 11/04/16
CTE Appendix 4D and Half year accountsPRICE SENSITIVE24/02/16
CTE Dividend/Distribution - CTE24/02/16
CTE Final Director's Interest Notice09/12/15
CTE Initial Director's Interest Notice09/12/15
CTE Appointment and resignation of director09/12/15
CTE Change of Director's Interest Notice02/12/15
CTE Expiry of unlisted options02/12/15
CTE Change in substantial holding26/11/15
CTE Change in substantial holding25/11/15
CTE Change of Director's Interest Notice25/11/15
CTE Results of Meeting10/11/15
CTE Chairman's Address to Shareholders10/11/15
CTE Notice of Annual General Meeting/Proxy Form02/10/15
CTE Annual Report to shareholders02/10/15
CTE Change of Director's Interest Notice09/09/15
CTE CEO resignationPRICE SENSITIVE03/09/15
CTE Appendix 4G Corporate Governance26/08/15
CTE Dividend/Distribution - CTE26/08/15
CTE Appendix 4E and Annual ReportPRICE SENSITIVE26/08/15
CTE Profit GuidancePRICE SENSITIVE29/05/15
CTE Change of Director's Interest Notice - Christy Boyce06/03/15
CTE Change in substantial holding05/03/15
CTE Change of Director's Interest Notice - Andrew Kroger05/03/15
CTE New - Appx 3A.1 Notification of Distribution - CTE25/02/15
CTE Appendix4D and Half Year Report and AccountsPRICE SENSITIVE25/02/15
CTE Change in substantial holding23/01/15
CTE Change of Director's Interest Notice23/01/15
CTE Appointment of CEOPRICE SENSITIVE20/01/15
CTE Results of MeetingPRICE SENSITIVE01/12/14
CTE Chairman's Address to Shareholders01/12/14
CTE Notice of General Meeting/Proxy Form30/10/14
CTE Results of Meeting22/10/14
CTE Chairman's Address to AGM22/10/14
CTE Notice of Annual General Meeting/Proxy Form18/09/14
CTE Annual Report 201418/09/14
CTE Appendix 4D and Half Year Accounts
26/02/19PRICE SENSITIVE
CTE Federal Court approves in principle settlement
13/02/19PRICE SENSITIVE
CTE Cryosite reaches in principle settlement with ACCC
08/02/19PRICE SENSITIVE
CTE Results of Meeting
23/11/18
CTE Notice of General Meeting/Proxy Form
19/10/18
CTE Corporate Governance Statement
30/08/18
CTE Appendix 4G
30/08/18
CTE Appendix4E and Annual report
30/08/18PRICE SENSITIVE
CTE Trading Update
02/08/18PRICE SENSITIVE
CTE ACCC proceedings
12/07/18PRICE SENSITIVE download Created with Sketch. 108.86KB
CTE Change in substantial holding
27/03/18
CTE Change of Director's Interest Notice
27/03/18
CTE Change in substantial holding
16/03/18
CTE Change of Director's Interest Notice
16/03/18
CTE Initial Director's Interest Notice
05/03/18
CTE Director appointment
05/03/18
CTE Final Director's Interest Notice
02/03/18
CTE Director resignation
02/03/18
CTE Appendix 4D and Half Year Report
28/02/18PRICE SENSITIVE
CTE Appendix 3B
16/02/18
CTE Appointment of CEO
17/01/18PRICE SENSITIVE
CTE Cell Care transaction not to proceed. Meeting Cancelled
09/01/18PRICE SENSITIVE
CTE ACCC update
21/12/17
CTE ACCC ends review of Cell Care's Cryosite assets acquisition
21/12/17PRICE SENSITIVE
CTE Notice of General Meeting/Proxy Form
14/12/17
CTE Appendix 3B
01/12/17
CTE Appendix 3B
28/11/17
CTE Trading update
22/11/17PRICE SENSITIVE
CTE ACCC update
08/11/17PRICE SENSITIVE
CTE Results of Meeting
03/11/17
CTE Chairman's Address to Shareholders
03/11/17PRICE SENSITIVE
CTE Change of Director's Interest Notice
11/10/17
CTE Notice of Annual General Meeting/Proxy Form
29/09/17
CTE Appendix 4G and Corporate Governance Statement
23/08/17
CTE Appendix 4E and Annual Report
23/08/17PRICE SENSITIVE
CTE ACCC review of proposed transaction of Cord Blood assets
04/08/17PRICE SENSITIVE
CTE Change in substantial holding
03/07/17
CTE Change of Director's Interest Notice
03/07/17
CTE Appendix 3c - share buyback
23/06/17
CTE Cryosite to license its CB&T brand and sell certain assets
23/06/17PRICE SENSITIVE
CTE Appointment of Interim CEO
15/06/17PRICE SENSITIVE
CTE Resignation of CEO
19/05/17PRICE SENSITIVE
CTE CEO - introduction of short and long term incentive plan
08/03/17
CTE Appendix 3B - performance rights
08/03/17
CTE Dividend/Distribution - CTE
22/02/17
CTE Appendix 4D and Half Year Accounts
22/02/17PRICE SENSITIVE
CTE Revised Share Trading Policy
07/02/17
CTE Change of Director's Interest Notice
06/01/17
CTE Change of Director's Interest Notice - S Roberts
20/12/16
CTE Change of Director's Interest Notice - S Roberts
13/12/16
CTE Director appointment resignation appendix 3x and 3y-CTE.AX
03/11/16
CTE Director appointment resignation appendix 3x and 3y
03/11/16
CTE Results of Meeting-CTE.AX
27/10/16
CTE Chairman's Address to Shareholders-CTE.AX
27/10/16
CTE Notice of General Meeting/Proxy Form-CTE.AX
22/09/16
CTE Change in substantial holding-CTE.AX
01/09/16
CTE Change of Director's Interest Notice-CTE.AX
01/09/16
CTE Appendix 4G and Corporate Governance Statement-CTE.AX
24/08/16
CTE Dividend/Distribution - CTE-CTE.AX
24/08/16
CTE Appendix 4E and audited annual report-CTE.AX
24/08/16PRICE SENSITIVE
CTE Change of Director's Interest Notice-CTE.AX
05/07/16
CTE Appointment of CEO-CTE.AX
08/06/16PRICE SENSITIVE
CTE Corporate Governance Statement-CTE.AX
21/04/16
CTE Change in position of Chairman-CTE.AX
11/04/16
CTE Cryosite assists Stemlife customers-CTE.AX
11/04/16
CTE Appendix 4D and Half year accounts
24/02/16PRICE SENSITIVE
CTE Dividend/Distribution - CTE
24/02/16
CTE Final Director's Interest Notice
09/12/15
CTE Initial Director's Interest Notice
09/12/15
CTE Appointment and resignation of director
09/12/15
CTE Change of Director's Interest Notice
02/12/15
CTE Expiry of unlisted options
02/12/15
CTE Change in substantial holding
26/11/15
CTE Change in substantial holding
25/11/15
CTE Change of Director's Interest Notice
25/11/15
CTE Results of Meeting
10/11/15
CTE Chairman's Address to Shareholders
10/11/15
CTE Notice of Annual General Meeting/Proxy Form
02/10/15
CTE Annual Report to shareholders
02/10/15
CTE Change of Director's Interest Notice
09/09/15
CTE CEO resignation
03/09/15PRICE SENSITIVE
CTE Appendix 4G Corporate Governance
26/08/15
CTE Dividend/Distribution - CTE
26/08/15
CTE Appendix 4E and Annual Report
26/08/15PRICE SENSITIVE
CTE Profit Guidance
29/05/15PRICE SENSITIVE
CTE Change of Director's Interest Notice - Christy Boyce
06/03/15
CTE Change in substantial holding
05/03/15
CTE Change of Director's Interest Notice - Andrew Kroger
05/03/15
CTE New - Appx 3A.1 Notification of Distribution - CTE
25/02/15
CTE Appendix4D and Half Year Report and Accounts
25/02/15PRICE SENSITIVE
CTE Change in substantial holding
23/01/15
CTE Change of Director's Interest Notice
23/01/15
CTE Appointment of CEO
20/01/15PRICE SENSITIVE
CTE Results of Meeting
01/12/14PRICE SENSITIVE
CTE Chairman's Address to Shareholders
01/12/14
CTE Notice of General Meeting/Proxy Form
30/10/14
CTE Results of Meeting
22/10/14
CTE Chairman's Address to AGM
22/10/14
CTE Notice of Annual General Meeting/Proxy Form
18/09/14
CTE Annual Report 2014
18/09/14
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
85.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $39.04M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 630 80.0¢
 

Sellers (Offers)

Price($) Vol. No.
85.0¢ 39 1
View Market Depth
Last trade - 10.02am 04/12/2024 (20 minute delay) ?
CTE (ASX) Chart

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Anatara reaches required level for recruitment in trial for IBS treament Anatara Life Sciences Ltd has successfully enrolled 60 people in its Stage 2 trial to test its Gastrointestinal ReProgramming (GaRP) treatment
Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising! Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
Commonwealth Bank backflips on 'greedy' $3 withdrawal charge that had basically everyone furious The Commonwealth Bank (ASX:CBA) has nearly immediately rescinded plans to charge its banking customers $3 to withdraw their own money at branches or the post office after a groundswell of outrage across the country.The biggest bank in Australia drew ire through this week after unveiling plans to ...
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.